Skip to main content

Multiplex Immunofluorescence Profiling of Tumor Biopsies Using UltraPlex mxIF Technology

Helen Snyder, PhD, Director of Preclinical Development and Strategic Partnerships Cell IDx
Marie-Louise Loupart, PhD, Image Analysis Specialist for Leica Biosystems Aperio ePathology

Entre em contacto connosco para obter um orçamento.

An unmet need in tissue diagnostics is the ability to simultaneously detect three or more markers on a single tissue specimen, i.e. multiplexing. Unlike other immunoassays, i.e. flow cytometry, ELISA and bead assays, which solely quantify the biomarker in a sample, a multiplex immunoassay quantifies the biomarker, identifies the location of the cell in the tissue and identifies the spatial relationship of the biomarkers with respect to each other. Being able to identify the contextual relationships of immune cell phenotypes and other biomarkers in a tumor is believed to be critical to understanding the state of the immune system before and after immunotherapy. Multiplex immunostaining can also be described as image cytometry or flow cytometry in situ. Detecting multiple biomarkers on a single slide presents many challenges: correct selection of biomarkers, sourcing and qualifying antibodies against the biomarkers, detection methods, optimization of the staining-detection protocol and how to visualize, record and interpret the resulting complex staining pattern, all without generating artefact from cross-talk at each step. Today we shall demonstrate a complete solution for standardization of immunofluorescent staining and detection, digitization and analysis for tumor biopsy material. We have demonstrated that this protocol can be carried out on the Leica Biosystems BOND RX auto-stainer and the stained tissue can be imaged on the Aperio system that allows the user to easily digitize the whole slide at high-resolution, manage the resulting huge image files and provide accurate quantitative interpretation in the form of mark-up images and numerical data at the per cell level providing detailed phenotype information.

Learning Objectives

  • What is Multiplex and what is the role of multiplex in Digital Pathology?
  • What tools are available today for multiplex?

Leica Biosystems content is subject to the Leica Biosystems website terms of use, available at: Legal Notice. The content, including webinars, training presentations and related materials is intended to provide general information regarding particular subjects of interest to health care professionals and is not intended to be, and should not be construed as, medical, regulatory or legal advice. The views and opinions expressed in any third-party content reflect the personal views and opinions of the speaker(s)/author(s) and do not necessarily represent or reflect the views or opinions of Leica Biosystems, its employees or agents. Any links contained in the content which provides access to third party resources or content is provided for convenience only.

For the use of any product, the applicable product documentation, including information guides, inserts and operation manuals should be consulted. Leica Biosystems and the editors hereby disclaim any liability arising directly or indirectly from the use of the content, including from any drugs, devices, techniques or procedures described in the content.

Copyright © 2022 Leica Biosystems division of Leica Microsystems, Inc. and its Leica Biosystems affiliates. All rights reserved. LEICA and the Leica Logo are registered trademarks of Leica Microsystems IR GmbH.

About the presenters

Helen Snyder, PhD, Director of Preclinical Development and Strategic Partnerships Cell IDx

Received her PhD in immunology from the University of Cambridge, UK and trained as a postdoctoral fellow at Scripps Research Institute, La Jolla, California. Dr. Snyder has over 30 years' experience in immunology research, reagent development, preclinical development of biotherapeutics, and business development of immunoassay and immunodiagnostic products. She has held positions as Associate Professor at the University of California, San Diego, as well as Director of Immunology at Dynavax Technologies and key business development roles at both Solulink Biosciences and Cell IDx. Dr Snyder has over 40 papers and reviews in the areas of immune regulation and vaccine development and holds two patents.

Marie-Louise Loupart, PhD, Image Analysis Specialist for Leica Biosystems Aperio ePathology

Formerly, Product Support Specialist for CytoVision, Ariol & Aperio VERSA 2010-2016, Marie-Louise has a 13 years of experience in bio-medical research, being trained as a Molecular Biologist, extending into Cell Biology, Cytogenetics, Developmental Biology and Biochemistry during the course of research career. Marie-Louise received her PhD in Biological Sciences from University of Leicester for deletion-mapping in human breast cancer. She has also received two diverse post-doctoral research fellowships at the University of Edinburgh, creating human artificial chromosomes, and investigating Drosophila cell cycle mutants.